Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 26.29M | 25.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 26.29M | 25.34M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 26.29M | 25.34M |
| SG&A Expenses | -- | -- | -- | 19.25M | 17.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 1.29M | 684.00K |
| Total Operating Expenses | -- | -- | -- | 50.12M | 52.81M |
| Operating Income | -- | -- | -- | -23.83M | -27.48M |
| Income Before Tax | -- | -- | -- | -18.16M | -22.39M |
| Income Tax Expenses | -- | -- | -- | 198.50K | 145.00K |
| Earnings from Continuing Operations | -- | -- | -- | -18.36 | -22.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -18.36M | -22.54M |
| EBIT | -- | -- | -- | -23.83M | -27.48M |
| EBITDA | -- | -- | -- | -23.17M | -26.80M |
| EPS Basic | -- | -- | -- | -0.33 | -0.41 |
| Normalized Basic EPS | -- | -- | -- | -0.17 | -0.22 |
| EPS Diluted | -- | -- | -- | -0.33 | -0.41 |
| Normalized Diluted EPS | -- | -- | -- | -0.18 | -0.22 |
| Average Basic Shares Outstanding | -- | -- | -- | 220.83M | 220.63M |
| Average Diluted Shares Outstanding | -- | -- | -- | 221.35M | 221.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |